Security key
31572Q881
KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB)
CUSIP: 31572Q881
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 1,150,872
- Total 13F value
- $10,102,543
- Share change
- +18,551
- Put/Call ratio
- 20%
- SEC-reported price per share
- $8.78
- Number of holders
- 32
- Value change
- -$49,623
- Number of buys
- 12
- Number of sells
- 13
- Shares outstanding
- 4,044,489
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2025
Institutions
32
Top holders
10
KYNB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
KYNTRA BIO, INC. SEC filings
KYNTRA BIO, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31572Q881
Recent filing periods:
Ownership snapshot
Top reported holders of KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13F
13D/G
Lead comparable stake: 9.9%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
9.9%
PRIMECAP MANAGEMENT CO/CA/
4.6%
VANGUARD GROUP INC
4.4%
ACADIAN ASSET MANAGEMENT LLC
2.7%
BlackRock, Inc.
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
9.9%
from 13D/G
|
$4,630,500
378,000 shares
|
— | 30 Sep 2025 |
| PRIMECAP MANAGEMENT CO/CA/ |
13D/G
13F
Company
|
4.6%
|
$1,523,323
4,616,130 shares
|
$0 | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
4.4%
from 13D/G
|
$2,256,990
184,244 shares
|
— | 30 Sep 2025 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
2.7%
|
$1,349,000
110,281 shares
|
— | 30 Sep 2025 |
| BlackRock, Inc. |
13F
Company
|
2.1%
|
$1,038,200
84,751 shares
|
— | 30 Sep 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
1.8%
|
$887,501
72,449 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
32
Shares
1,150,872
Rows available
32
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
30
Q4 2025 holders
32
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend